New Delhi: As cardiovascular diseases surge across India, particularly among younger populations, the field of interventional cardiology is undergoing a quiet but powerful transformation. From smarter stent technologies to precision imaging and a stronger push for patient-centric care, experts say the future of heart treatment lies as much in innovation inside the cath lab as in patient behaviour outside it.
The advancement in drug-eluting stents (DES) have significantly improved patient outcomes over the past decade. “Patients today are less likely to require a second intervention after a stent procedure,” Dr Nils P Johnson, Professor of Cardiology, University of Texas, Houston says the transformation has been twofold—engineering and pharmacology.
“The small wire mesh structures that are placed in the arteries have become thinner and more refined. The second important development is the evolution of the drug coating on these stents and the way it is delivered into the blood vessel. It is now designed to be more compatible with the vessel’s natural healing process after the procedure,” he explains.
These incremental improvements are translating into tangible clinical gains. “Compared to stents used five or ten years ago, the likelihood of patients needing a repeat procedure is significantly lower,” he adds, noting that this has also strengthened clinicians’ confidence in long-term outcomes and patient selection.
But innovation in cardiology today is not just about better devices, it’s about better precision.
In a space where coronary arteries can be as small as a few millimetres, even marginal differences can significantly impact outcomes. “Blood vessels are often only about 5 millimetres in diameter, which highlights how limited the working space is,” says Dr Johnson. “In such small vessels, even a difference of half a millimetre is significant,” he adds.
This is where intravascular imaging tools like optical coherence tomography (OCT) are becoming indispensable. “They allow us to take precise measurements from inside the blood vessel, enabling us to select the most appropriate stent size and ensure optimal placement. Importantly, evidence shows that using a larger, well sized stent is associated with a lower likelihood of patients needing a repeat procedure,” he notes.
While technological progress is reshaping treatment, the epidemiology of heart disease is also evolving—particularly in India.
“The rise is indeed concerning, particularly among younger populations in India,” says Dr Sripal Bangalore, Professor of Medicine, New York University School of Medicine. “While traditional risk factors continue to play a role, there is growing evidence that non-traditional factors are also contributing significantly to this trend.”
Among these, lipoprotein(a), or Lp(a), is emerging as a key player. “Lp(a) is a cholesterol-containing particle in the blood. People with elevated Lp(a) are more likely to develop heart problems at a younger age,” he explains, adding that more research is needed to fully understand and address such risks.
Compounding the challenge is the increasing complexity of patients presenting for treatment, Dr. Bangalore said, “Patients today are frequently presenting with multiple comorbidities and more advanced, extensive disease. This makes decision-making more challenging,”
Yet, he remains optimistic. “The positive aspect is that we now have a wide range of advanced devices and treatment options to manage such cases effectively,” he notes.
Highlighting the growing adoption of a multidisciplinary ‘heart team’ approach, he said, “A multidisciplinary group of specialists collaborates with the patient to determine the most appropriate treatment strategy. This ensures more balanced, personalized, and well-informed care.”
Despite these advances, a critical gap persists—long-term outcomes.
“Treatment does not end in the cath lab. While we are increasingly able to achieve excellent immediate results in the cath lab, ensuring strong long-term outcomes remains a key challenge,” he cautions.
The missing link, experts agree, is patient adherence. “A critical gap lies in long-term patient adherence to medications and lifestyle changes. Patients play an essential role in their own recovery taking prescribed medications regularly, maintaining a healthy diet, exercising, or avoiding smoking,” says Dr. Bangalore.
As cardiology moves toward a more individualized approach, tailoring treatment to each patient’s unique risk profile is becoming central to improving outcomes. “Every decision we make needs to be tailored to the specific patient. Carefully weighing the risks and benefits of each treatment option is essential,” he says.
With India at the cusp of a cardiovascular crisis, the message from global experts is clear that innovation alone is not enough. The future of heart care will depend on integrating cutting-edge technology with precision medicine, and ensuring patients remain active partners in their own care journey.
